Evaluation · Diagnostic Workup
Practical Clinical and Diagnostic Pathway for the Investigation of the Infertile Couple
Garolla A et al., 2021
14 works
Antonio Lanzone
Regularly publishes research on Opioid Peptides, Ovulatory Disturbances, and Insulin Sensitizing Agents.
Subjects
14 works
Supplements and Botanicals · Antioxidant Supplements
N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome
Fulghesu AM et al., 2002
Ultrasound · Transvaginal Ultrasound
A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio
Fulghesu AM et al., 2001
Neuroendocrinology · Opioid Peptides
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study
Fulghesu AM et al., 2001
Neuroendocrinology · Opioid Peptides
Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism
Villa P et al., 1999
Thyroid and Metabolic Function · Insulin and Metabolism
Insulin and polycystic ovary syndrome: a new look at an old subject
Ciampelli M et al., 1998
Neuroendocrinology · Opioid Peptides
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease
Fulghesu AM et al., 1998
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
Effect of opioid blockade on insulin metabolism in polycystic ovarian disease
Fulghesu AM et al., 1995
Neuroendocrinology · Opioid Peptides
Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinizing hormone secretion
Lanzone A et al., 1995
Polycystic ovary disease. A risk factor for gestational diabetes?
Lanzone A et al., 1995
Long-term naltrexone treatment normalizes the pituitary response to gonadotropin-releasing hormone in polycystic ovarian syndrome
Lanzone A et al., 1993
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease
Fulghesu AM et al., 1993
Neuroendocrinology · Opioid Peptides
Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease
Lanzone A et al., 1991
Ovarian Hormones · Androgens
Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist
Lanzone A et al., 1990
